封面
市場調查報告書
商品編碼
1515451

稀有生物標記樣本採集和穩定市場,按生物標記、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Rare Biomarkers Specimen Collection and Stabilization Market, By Biomarker, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年,稀有生物標記樣本採集和穩定市場規模為 36,908.32 百萬美元,2024 年至 2032 年複合年成長率為 13.90%。

稀有生物標記標本採集與穩定市場-市場動態

藥物開發、臨床試驗和生物醫學研究數量的增加預計將推動市場需求

生物標記擴大用作臨床試驗中的終點來評估藥物的功效和安全性。正確收集和穩定稀有生物標記對於確保試驗結果的可靠性和可重複性至關重要。此外,樣品處理技術的創新,例如改進的穩定劑、儲存條件和運輸系統,提高了稀有生物標記收集和穩定過程的可靠性和效率。因此,臨床試驗和技術進步的高需求預計將促進市場成長。

生物技術和分子生物學的技術發展提高了我們發現和檢查不常見生物標記的能力。這強調了需要可靠的技術來穩定和收集樣本,同時保持生物標記的完整性,從而促進市場成長。考慮到患者的遺傳、環境和生物標記特徵,治療變得更加個人化,稱為個人化醫療。為了找出影響治療效果和結果的患者特異性特徵,稀有生物標記至關重要。人們越來越重視具有成本效益的醫療保健解決方案。基於生物標記的診斷可以透過實現早期疾病檢測和標靶治療來降低整體醫療成本。

稀有生物標記標本採集和穩定市場 - 關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2024-2032)每年將以 13.90% 左右的複合年成長率成長

根據生物標記細分,由於癌症治療的高需求,循環遊離 DNA (ccfDNA) 片段預計將在 2023 年顯示最大的市場佔有率。

根據應用細分,由於慢性病護理需求的增加,診斷細分是 2023 年的領先應用。

根據最終用戶細分,由於高度關注藥物開發和新穎研究,研究實驗室細分市場在 2023 年成為領先的最終用戶。

從地區來看,由於政府的支持和 FDA 的批准,北美是 2023 年的主要收入來源。

稀有生物標記樣本採集與穩定市場-細分分析:

全球稀有生物標記樣本採集和穩定市場根據生物標記、應用、最終用戶和地區進行細分。

根據生物標記將市場分為三類:循環無細胞DNA、循環腫瘤細胞和外泌體。環狀無細胞 DNA 片段在市場上佔據主導地位。血癌的高盛行率主要促進了細分市場的成長。

市場依應用分為五類:診斷、轉錄組學、藥物基因組學、心血管疾病等。診斷領域佔據市場主導地位。對非侵入性癌症治療和臨床使用的需求不斷成長正在加速市場成長。

根據最終用戶,市場分為三類:研究實驗室、醫院和診所等。研究實驗室領域在市場中佔據主導地位,預計在預測期內將保持其高度主導地位。政府和 FDA 對 DNA 和 RNA 藥物開發的批准不斷增加,正在推動市場成長。

稀有生物標記標本採集和穩定市場 - 地理洞察

從地理來看,該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。北美(主要是美國)是先進生物醫學研究和診斷的成熟市場。領先學術機構、研究中心和生物技術公司的存在等幾個因素推動了對先進標本採集和穩定技術的需求。此外,大量的醫療保健支出和保險覆蓋範圍促進了先進診斷技術的採用。

稀有生物標記標本採集與穩定市場-競爭格局:

稀有生物標記標本採集和穩定市場的競爭格局是由主要參與者主導的技術進步決定的。市場上一些領先的公司,如賽默飛世爾科技(Thermo Fisher Scientific)、凱傑(QIAGEN)、BD Biosciences、默克(Merck KGaA) 等,由於其廣泛的產品供應和全球影響力而佔據著市場占有率.這些公司正在投資研發,以創新新的樣本收集設備和穩定方法,以提高生物標記的保存和可靠性。

最近的發展:

2023 年 3 月,nRichDX 與 OraSure Technologies, Inc. 合作,向從事液體活體組織切片應用的科學家推銷他們的產品。

2023 年 5 月,LabCorp 推出了 LabCorp Plasma Focus,這是一種液體活體組織切片測試,可為晚期或轉移性實體癌症患者提供量身定做的治療選擇。

目錄

第 1 章:稀有生物標記樣本採集與穩定市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • Biomarker 的稀有生物標記物樣本採集和穩定市場片段
    • 稀有生物標記樣本採集和穩定市場片段(按應用)
    • 最終用戶的稀有生物標記樣本採集和穩定市場片段
    • 稀有生物標記樣本採集和穩定市場片段(按國家/地區)
    • 稀有生物標記樣本採集和穩定市場片段(按地區)
  • 競爭洞察

第 3 章:稀有生物標記樣本採集和穩定主要市場趨勢

  • 稀有生物標記標本採集與穩定市場促進因素
    • 市場促進因素的影響分析
  • 稀有生物標記標本採集與穩定市場限制
    • 市場限制影響分析
  • 稀有生物標記樣本採集和穩定市場機會
  • 稀有生物標記標本採集與穩定市場未來趨勢

第 4 章:稀有生物標記樣本採集與穩定產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:稀有生物標記標本採集與穩定市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章:稀有生物標記樣本採集與穩定市場格局

  • 稀有生物標記標本採集與穩定市場佔有率分析,2023 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:稀有生物標記樣本採集和穩定市場 - 按生物標記

  • 概述
    • 按 Biomarker 分類的細分市場佔有率分析
    • 環狀無細胞DNA
    • 循環腫瘤細胞
    • 外泌體

第 8 章:稀有生物標記樣本收集和穩定市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 診斷
    • 轉錄組學
    • 藥物基因組學
    • 心血管疾病
    • 其他

第 9 章:稀有生物標記樣本採集和穩定市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 研究實驗室
    • 醫院及診所
    • 其他

第 10 章:稀有生物標記標本採集和穩定市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 稀有生物標記標本採集和穩定北美主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測,按 Biomarker 分類
    • 北美市場規模和預測(按應用)
    • 北美市場規模和預測(按最終用戶)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 稀有生物標記標本採集和穩定歐洲主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模與預測,按 Biomarker 分類
    • 歐洲市場規模和預測(按應用)
    • 歐洲市場規模和預測(按最終用戶)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 稀有生物標記標本採集和穩定化亞太地區主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模與預測(按 Biomarker 分類)
    • 亞太地區市場規模與預測(按應用)
    • 亞太地區市場規模和預測(按最終用戶)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 稀有生物標記標本採集和穩定拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測,按 Biomarker 分類
    • 拉丁美洲市場規模與預測(按應用)
    • 拉丁美洲市場規模和預測(按最終用戶)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 稀有生物標記標本採集和穩定中東和非洲主要製造商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測,按 Biomarker 分類
    • 中東和非洲市場規模及預測(按應用)
    • 中東和非洲市場規模及預測(按最終用戶)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章:主要供應商分析 - 稀有生物標記樣本採集和穩定產業

  • 競爭儀表板
  • 公司簡介
    • Thermo Fisher Scientific
    • QIAGEN
    • BD Biosciences
    • Merck KGaA
    • Bio-Rad Laboratories
    • Bio-Techne Corporation
    • GE Healthcare Life Sciences
    • Agilent Technologies
    • Roche Diagnostics
    • LabCorp
    • Promega Corporation
    • Illumina, Inc.
    • Danaher Corporation
    • PerkinElmer, Inc.
    • Eppendorf AG
    • Lonza Group
    • Others

第 12 章:360 度分析師視角

第 13 章:附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3173

REPORT HIGHLIGHT

Rare Biomarkers Specimen Collection and Stabilization Market size was valued at USD 36,908.32 Million in 2023, expanding at a CAGR of 13.90% from 2024 to 2032.

Rare biomarkers specimen collection and stabilization refers to the process of obtaining biological samples such as blood, urine, tissue, etc. that contain rare or low-abundance biomolecules, which are substances indicative of biological processes or conditions. These biomarkers may be present in very small quantities in the body and can provide critical information about disease states, treatment responses, or physiological changes.

Rare Biomarkers Specimen Collection and Stabilization Market- Market Dynamics

Rising number of drug development & clinical trials and biomedical research are expected to propel market demand

Biomarkers are increasingly used as endpoints in clinical trials to assess drug efficacy and safety. Proper collection and stabilization of rare biomarkers are critical to ensuring the reliability and reproducibility of trial results. Moreover, innovations in sample handling technologies, such as improved stabilizing agents, storage conditions, and transport systems, enhance the reliability and efficiency of rare biomarker collection and stabilization processes. Thus, high demand from clinical trials & advancement in technology is expected to foster market growth.

Technological developments in biotechnology and molecular biology have increased our capacity to find and examine uncommon biomarkers. This emphasizes the necessity for trustworthy techniques for stabilizing and collecting specimens while maintaining the integrity of the biomarker which is contributing to market growth. Treatments are becoming more individualized considering patient genetic, environmental, and biomarker profiles known as personalized medicine. To pinpoint patient-specific traits that affect therapy efficacy and outcomes, rare biomarkers are essential. There is a growing emphasis on cost-effective healthcare solutions. Biomarker-based diagnostics can potentially reduce overall healthcare costs by enabling early disease detection and targeted therapies.

Rare Biomarkers Specimen Collection and Stabilization Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.90% over the forecast period (2024-2032)

Based on Biomarker segmentation, circulating cell-free DNA (ccfDNA) segment was predicted to show maximum market share in the year 2023, owing to its high demand in cancer treatment.

Based on Application segmentation, diagnostics segment was the leading application in 2023, due to increased need for chronic disorder care.

Based on End User segmentation, research laboratories segment was the leading End User in 2023, owing to high focus on drug development & novel research.

On the basis of region, North America was the leading revenue generator in 2023, owing to government support & FDA approvals.

Rare Biomarkers Specimen Collection and Stabilization Market- Segmentation Analysis:

The Global Rare Biomarkers Specimen Collection and Stabilization Market is segmented on the basis of Biomarker, Application, End User, and Region.

The market is divided into three categories based on Biomarker: circular cell free DNA, circulating tumor cells, and exosomes. The circular cell free DNA segment dominates the market. High prevalence of blood cancer is primarily boosting segment growth.

The market is divided into five categories based on Application: diagnostics, transcriptomics, pharmacogenomics, cardiovascular diseases, and others. The diagnostics segment dominates the market. The increasing need for treatment of non-invasive cancer and clinical use is accelerating market growth.

The market is divided into three categories based on End User: research laboratories, hospital & clinics, and others. The research laboratories segment dominates the market and is expected to maintain its high dominance during the forecast period. The increasing encouragement from government & FDA approvals in DNA & RNA drug development are boosting market growth.

Rare Biomarkers Specimen Collection and Stabilization Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, mainly the United States, is a mature market for advanced biomedical research and diagnostics. Several factors like the presence of leading academic institutions, research centers, and biotechnology companies drive demand for advanced specimen collection and stabilization technologies. In addition, significant healthcare spending and insurance coverage facilitate adoption of advanced diagnostic technologies.

Rare Biomarkers Specimen Collection and Stabilization Market- Competitive Landscape:

The competitive landscape of the rare biomarkers specimen collection and stabilization market is shaped by technological advancements, dominated by major players. some of the leading companies in the market such as Thermo Fisher Scientific, QIAGEN, BD Biosciences, Merck KGaA, etc., dominate market share due to their extensive product offerings and global presence. These companies are investing in research and development to innovate new specimen collection devices and stabilization methods that improve biomarker preservation and reliability.

Recent Developments:

In March 2023, nRichDX partnered with OraSure Technologies, Inc., to market their products for scientists working on liquid biopsy applications.

In May 2023, LabCorp launched LabCorp Plasma Focus, a liquid biopsy test which enables tailored therapy selection for people with advanced or metastatic solid cancers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • QIAGEN
  • BD Biosciences
  • Merck KGaA
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • GE Healthcare Life Sciences
  • Agilent Technologies
  • Roche Diagnostics
  • LabCorp
  • Promega Corporation
  • Illumina, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Eppendorf AG
  • Lonza Group
  • Others

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET, BY BIOMARKER- MARKET ANALYSIS, 2019-2032

  • Circular Cell Free DNA
  • Circulating tumor cells
  • Exosomes

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Diagnostics
  • Transcriptomics
  • Pharmacogenomics
  • Cardiovascular diseases
  • Others

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Research laboratories
  • Hospital & clinics
  • Others

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Rare Biomarkers Specimen Collection and Stabilization Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by Biomarker
    • 2.1.2. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by Application
    • 2.1.3. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by End User
    • 2.1.4. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by Country
    • 2.1.5. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by Region
  • 2.2. Competitive Insights

3. Rare Biomarkers Specimen Collection and Stabilization Key Market Trends

  • 3.1. Rare Biomarkers Specimen Collection and Stabilization Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Rare Biomarkers Specimen Collection and Stabilization Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Rare Biomarkers Specimen Collection and Stabilization Market Opportunities
  • 3.4. Rare Biomarkers Specimen Collection and Stabilization Market Future Trends

4. Rare Biomarkers Specimen Collection and Stabilization Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Rare Biomarkers Specimen Collection and Stabilization Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Rare Biomarkers Specimen Collection and Stabilization Market Landscape

  • 6.1. Rare Biomarkers Specimen Collection and Stabilization Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Rare Biomarkers Specimen Collection and Stabilization Market - By Biomarker

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Biomarker, 2024 & 2032 (%)
    • 7.1.2. Circular Cell Free DNA
    • 7.1.3. Circulating tumor cells
    • 7.1.4. Exosomes

8. Rare Biomarkers Specimen Collection and Stabilization Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Diagnostics
    • 8.1.3. Transcriptomics
    • 8.1.4. Pharmacogenomics
    • 8.1.5. Cardiovascular diseases
    • 8.1.6. Others

9. Rare Biomarkers Specimen Collection and Stabilization Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Research laboratories
    • 9.1.3. Hospital & clinics
    • 9.1.4. Others

10. Rare Biomarkers Specimen Collection and Stabilization Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Rare Biomarkers Specimen Collection and Stabilization Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. QIAGEN
    • 11.2.3. BD Biosciences
    • 11.2.4. Merck KGaA
    • 11.2.5. Bio-Rad Laboratories
    • 11.2.6. Bio-Techne Corporation
    • 11.2.7. GE Healthcare Life Sciences
    • 11.2.8. Agilent Technologies
    • 11.2.9. Roche Diagnostics
    • 11.2.10. LabCorp
    • 11.2.11. Promega Corporation
    • 11.2.12. Illumina, Inc.
    • 11.2.13. Danaher Corporation
    • 11.2.14. PerkinElmer, Inc.
    • 11.2.15. Eppendorf AG
    • 11.2.16. Lonza Group
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Rare Biomarkers Specimen Collection and Stabilization Market: Biomarker Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Biomarker
  • TABLE Global Rare Biomarkers Specimen Collection and Stabilization Market, by Biomarker 2019-2032 (USD Million)
  • TABLE Rare Biomarkers Specimen Collection and Stabilization Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Rare Biomarkers Specimen Collection and Stabilization Market, by Application 2019-2032 (USD Million)
  • TABLE Rare Biomarkers Specimen Collection and Stabilization Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Rare Biomarkers Specimen Collection and Stabilization Market, by End User 2019-2032 (USD Million)
  • TABLE Rare Biomarkers Specimen Collection and Stabilization Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Rare Biomarkers Specimen Collection and Stabilization Market, by Region 2019-2032 (USD Million)
  • TABLE North America Rare Biomarkers Specimen Collection and Stabilization Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Rare Biomarkers Specimen Collection and Stabilization Market, by Biomarker, 2019-2032 (USD Million)
  • TABLE North America Rare Biomarkers Specimen Collection and Stabilization Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Rare Biomarkers Specimen Collection and Stabilization Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Rare Biomarkers Specimen Collection and Stabilization Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Rare Biomarkers Specimen Collection and Stabilization Market, by Biomarker, 2019-2032 (USD Million)
  • TABLE Europe Rare Biomarkers Specimen Collection and Stabilization Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Rare Biomarkers Specimen Collection and Stabilization Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rare Biomarkers Specimen Collection and Stabilization Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rare Biomarkers Specimen Collection and Stabilization Market, by Biomarker, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rare Biomarkers Specimen Collection and Stabilization Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rare Biomarkers Specimen Collection and Stabilization Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Rare Biomarkers Specimen Collection and Stabilization Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Rare Biomarkers Specimen Collection and Stabilization Market, by Biomarker, 2019-2032 (USD Million)
  • TABLE Latin America Rare Biomarkers Specimen Collection and Stabilization Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Rare Biomarkers Specimen Collection and Stabilization Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market, by Biomarker, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Rare Biomarkers Specimen Collection and Stabilization Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Biomarker segment market share analysis, 2023 & 2030
  • FIGURE Biomarker segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Rare Biomarkers Specimen Collection and Stabilization Market share and leading players, 2023
  • FIGURE Europe Rare Biomarkers Specimen Collection and Stabilization Market share and leading players, 2023
  • FIGURE Asia Pacific Rare Biomarkers Specimen Collection and Stabilization Market share and leading players, 2023
  • FIGURE Latin America Rare Biomarkers Specimen Collection and Stabilization Market share and leading players, 2023
  • FIGURE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Rare Biomarkers Specimen Collection and Stabilization Market share analysis by country, 2023
  • FIGURE Germany Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Rare Biomarkers Specimen Collection and Stabilization Market share analysis by country, 2023
  • FIGURE India Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Philippines Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Rare Biomarkers Specimen Collection and Stabilization Market share analysis by country, 2023
  • FIGURE Brazil Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market share analysis by country, 2023
  • FIGURE Saudi Arabia Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)